Related Experiment Videos
Ca(2+)/calmodulin-dependent protein kinase IV expression in epithelial ovarian cancer
Noriyuki Takai1, Tami Miyazaki, Masakazu Nishida
1Department of Obstetrics and Gynecology, Oita Medical University, 879-5593, Oita, Japan. takai@oita-med.ac.jp
Abstract:
Ca(2+)/calmodulin-dependent protein kinase IV (CaMKIV) is a multifunctional protein kinase expressed abundantly in the central nervous system. Because changes in intracellular Ca(2+) concentrations affect progression through the mitotic cell cycle, enhanced expression of CaMKIV has been reported in small cell lung carcinoma and hepatocellular carcinoma. To elucidate the involvement of CaMKIV in epithelial ovarian carcinogenesis, we analyzed serial frozen sections for CaMKIV protein expression in 26 patients with ovarian epithelial carcinoma and ten patients with benign cystadenoma of the ovary by fluorescent immunohistochemistry. We analyzed the relationship between the percentages of CaMKIV-stained cells and the patient's characteristics, including histological classification, clinical stage, histological grade, and clinical outcome. In the benign ovarian cystadenoma, CaMKIV was detected in none of the cases examined. Most of the CaMKIV proteins were found in the nucleus of epithelial ovarian cancer tissue. CaMKIV expression was significantly associated with clinical stage (P<0.01), histological grade (P<0.01), and clinical outcome (P<0.01). Survival data were available for all patients, and univariate Cox regression analysis showed that CaMKIV expression was significantly associated with poor prognosis (P<0.05). Our results demonstrate that CaMKIV expression in epithelial ovarian cancer correlates with the malignant potential of this tumor.
Insights
Calcium/calmodulin-dependent protein kinase IV (CaMKIV) is elevated in ovarian cancer, correlating with poor prognosis. This protein kinase
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Ca(2+)/calmodulin-dependent protein kinase IV (CaMKIV) is a key regulator of gene expression and cell proliferation.
- CaMKIV's role in cell cycle progression suggests potential involvement in carcinogenesis.
- Enhanced CaMKIV expression is observed in other cancer types, including lung and liver carcinomas.
Purpose of the Study:
- To investigate the expression and clinical significance of CaMKIV in epithelial ovarian carcinogenesis.
- To determine the correlation between CaMKIV expression levels and clinicopathological features of ovarian cancer.
- To assess the prognostic value of CaMKIV in patients with epithelial ovarian cancer.
Main Methods:
- Fluorescent immunohistochemistry was used to analyze CaMKIV protein expression in ovarian tissues.
- Samples included 26 patients with epithelial ovarian carcinoma and 10 with benign cystadenoma.
- Statistical analysis, including univariate Cox regression, was performed to correlate CaMKIV expression with patient characteristics and outcomes.
Main Results:
- CaMKIV was not detected in benign ovarian cystadenoma tissues.
- CaMKIV protein was predominantly localized in the nucleus of epithelial ovarian cancer cells.
- CaMKIV expression significantly correlated with advanced clinical stage, higher histological grade, and poorer clinical outcome (P<0.01).
Conclusions:
- CaMKIV expression is significantly associated with the malignant potential of epithelial ovarian cancer.
- CaMKIV expression serves as a potential biomarker for poor prognosis in ovarian cancer patients.
- Targeting CaMKIV may represent a therapeutic strategy for epithelial ovarian cancer.